Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 4:44 PM View:  | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 67,695 | $0.57 | $38,328.90 | (13%) 519.75K to 452.06K | |
| 08-Oct-24 4:44 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 230,645 | -- | -- | 80% 289.11K to 519.75K | |
| 11-Sep-24 4:01 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 09-Sep-24 | Sale | 2,642 | $0.66 | $1,737.64 | (< 1%) 291.75K to 289.11K | |
| 11-Mar-24 5:19 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 15,409 | $0.88 | $13,590.70 | (5%) 307.16K to 291.75K | |
| 12-Feb-24 5:23 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale | 3,683 | $1.01 | $3,708.78 | (1%) 310.84K to 307.16K | |
| 03-Nov-23 4:40 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 67,695 | $0.73 | $49,417.40 | (18%) 378.54K to 310.84K | |
| 02-Nov-23 4:55 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 230,645 | -- | -- | 156% 147.89K to 378.54K | |
| 12-Sep-23 4:04 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 08-Sep-23 | Sale (Planned) | 2,642 | $1.25 | $3,299.86 | (2%) 150.54K to 147.89K | |
| 05-Jul-23 4:05 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-23 | Market Sale (Planned) | 464 | $1.89 | $876.96 | (< 1%) 151.0K to 150.54K | (12%) |
| 26-Jun-23 4:15 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-23 | Market Sale (Planned) | 857 | $1.93 | $1,654.01 | (< 1%) 151.86K to 151.0K | (10%) |
| 13-Mar-23 4:52 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 10-Mar-23 | Sale | 18,192 | $0.84 | $15,281.30 | (11%) 170.91K to 152.71K | |
| 15-Feb-23 5:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 13-Feb-23 | Sale | 4,348 | $0.93 | $4,043.64 | (2%) 175.25K to 170.91K | |
| 19-Aug-22 1:07 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-22 | Sale (Planned) | 1,713 | -- | -- | (< 1%) 179.61K to 177.9K | |
| 01-Jul-22 4:56 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-22 | Sale (Planned) | 1,578 | -- | -- | (< 1%) 181.19K to 179.61K | |
| 27-Jun-22 4:09 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Jun-22 | Sale | 856 | -- | -- | (< 1%) 182.04K to 181.19K | |
| 17-Jun-22 4:21 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 16-Jun-22 | Sale (Planned) | 856 | -- | -- | (< 1%) 182.9K to 182.04K | |
| 01-Mar-22 4:16 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Mar-22 | Grant | 105,000 | -- | -- | 135% 77.9K to 182.9K | |
| 14-Feb-22 10:00 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Feb-22 | Sale (Planned) | 12,545 | -- | -- | (14%) 90.44K to 77.9K | |
| 10-Sep-21 4:10 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 08-Sep-21 | Grant | 27,000 | -- | -- | 43% 63.44K to 90.44K |